{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:07:24Z","timestamp":1790312844988,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"vor","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-GM110129"],"award-info":[{"award-number":["R01-GM110129"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-GM118000"],"award-info":[{"award-number":["R01-GM118000"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R37-AI064046"],"award-info":[{"award-number":["R37-AI064046"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21-CA206309"],"award-info":[{"award-number":["R21-CA206309"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["F31-CA183246"],"award-info":[{"award-number":["F31-CA183246"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.chembiol.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T19:49:57Z","timestamp":1510861797000},"page":"36-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["APOBEC Enzymes as Targets for Virus and Cancer Therapy"],"prefix":"10.1016","volume":"25","author":[{"given":"Margaret E.","family":"Olson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Harki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2017.10.007_bib1","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/S1462399409001343","article-title":"Interactions of host APOBEC3 restriction factors with HIV-1 in\u00a0vivo: implications for therapeutics","volume":"12","author":"Albin","year":"2010","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.chembiol.2017.10.007_bib2","doi-asserted-by":"crossref","first-page":"34083","DOI":"10.1074\/jbc.C400235200","article-title":"APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein","volume":"279","author":"Alce","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2017.10.007_bib4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cmdc.201200079","article-title":"Synthesis and structure-activity relationship studies of\u00a0HIV-1 virion infectivity factor (Vif) inhibitors that block viral replication","volume":"7","author":"Ali","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.chembiol.2017.10.007_bib5","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1081\/NCN-200059981","article-title":"Lentiviral-mediated delivery of combined HIV-1 decoy TAR and Vif siRNA as a single RNA molecule that cleaves to inhibit HIV-1 in transduced cells","volume":"24","author":"Barnor","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.chembiol.2017.10.007_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbrc.2004.05.201","article-title":"Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 Vif gene inhibits viral replication in infected T-lymphoblastoid cells","volume":"320","author":"Barnor","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chembiol.2017.10.007_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2016.11.001","article-title":"An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation","volume":"136","author":"Bennett","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.chembiol.2017.10.007_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1006\/jmbi.1994.1018","article-title":"Cytidine deaminase. The 2.3 \u00c5 crystal structure of an enzyme: transition-state analog complex","volume":"235","author":"Betts","year":"1994","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib10","doi-asserted-by":"crossref","first-page":"8450","DOI":"10.1128\/JVI.00839-06","article-title":"Antiviral potency of APOBEC proteins does not correlate with cytidine deamination","volume":"80","author":"Bishop","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib11","doi-asserted-by":"crossref","first-page":"e1000231","DOI":"10.1371\/journal.ppat.1000231","article-title":"APOBEC3G inhibits elongation of HIV-1 reverse transcripts","volume":"4","author":"Bishop","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2017.10.007_bib12","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1261\/rna.964708","article-title":"Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation","volume":"14","author":"Bogerd","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.chembiol.2017.10.007_bib13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jmb.2011.03.058","article-title":"Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif","volume":"410","author":"Britan-Rosich","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.virol.2009.02.026","article-title":"Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent","volume":"387","author":"Browne","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.chembiol.2017.10.007_bib15","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1128\/JVI.02237-06","article-title":"APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker","volume":"81","author":"Burnett","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature11881","article-title":"APOBEC3B is an enzymatic source of mutation in breast cancer","volume":"494","author":"Burns","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2017.10.007_bib17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ng.2701","article-title":"Evidence for APOBEC3B mutagenesis in multiple human cancers","volume":"45","author":"Burns","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2017.10.007_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.dnarep.2010.02.010","article-title":"Determinants of sequence-specificity within human AID and APOBEC3G","volume":"9","author":"Carpenter","year":"2010","journal-title":"DNA Repair"},{"key":"10.1016\/j.chembiol.2017.10.007_bib19","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.M109.085308","article-title":"Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G","volume":"285","author":"Cen","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib20","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1038\/mtna.2013.48","article-title":"Preclinical in\u00a0vivo evaluation of the safety of a multi-shRNA-based gene therapy against HIV-1","volume":"2","author":"Centlivre","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.chembiol.2017.10.007_bib21","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1073\/pnas.1424869112","article-title":"APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation","volume":"112","author":"Cescon","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2017.10.007_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-genet-112414-054714","article-title":"Clusters of multiple mutations: incidence and molecular mechanisms","volume":"49","author":"Chan","year":"2015","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.chembiol.2017.10.007_bib23","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1016\/S0021-9258(19)45812-2","article-title":"Cytidine deaminase from Escherichia coli. Purification, properties and inhibition by the potential transition state analog 3,4,5,6-tetrahydrouridine","volume":"246","author":"Cohen","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/gb-2008-9-6-229","article-title":"The AID\/APOBEC family of nucleic acid mutators","volume":"9","author":"Conticello","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib25","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.cub.2003.10.034","article-title":"The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G","volume":"13","author":"Conticello","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/molbev\/msi026","article-title":"Evolution of the AID\/APOBEC family of polynucleotide (deoxy)cytidine deaminases","volume":"22","author":"Conticello","year":"2005","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","article-title":"Molecular mechanisms of antibody somatic hypermutation","volume":"76","author":"Di Noia","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib28","first-page":"613","article-title":"An anti-HIV-1 compound that increases steady-state expression of apoplipoprotein B\u00a0mRNA-editing enzyme-catalytic polypeptide-like 3G","volume":"28","author":"Ejima","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.chembiol.2017.10.007_bib29","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1016\/j.bmc.2010.06.052","article-title":"Baculiferins A-O, O-sulfated pyrrole alkaloids with anti-HIV-1 activity, from the Chinese marine sponge Iotrochota baculifera","volume":"18","author":"Fan","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib30","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1126\/science.3497453","article-title":"The sor gene of HIV-1 is required for efficient virus transmission in\u00a0vitro","volume":"237","author":"Fisher","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2017.10.007_bib31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0026-895X(25)13486-X","article-title":"The inhibition of DNA(cytosine-5)methylases by 5-azacytidine","volume":"19","author":"Friedman","year":"1981","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib32","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1128\/JVI.66.11.6489-6495.1992","article-title":"Role of Vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes","volume":"66","author":"Gabuzda","year":"1992","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature12884","article-title":"Structural basis for hijacking CBF-beta and CUL5 E3 ligase complex by HIV-1 Vif","volume":"505","author":"Guo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2017.10.007_bib34","first-page":"148","article-title":"Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance","volume":"8","author":"Hach\u00e9","year":"2006","journal-title":"AIDS Rev."},{"key":"10.1016\/j.chembiol.2017.10.007_bib35","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.1128\/JVI.03173-12","article-title":"Impact of H216 on the DNA binding and catalytic activities of the HIV restriction factor APOBEC3G","volume":"87","author":"Harjes","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nbt1008-1089","article-title":"Enhancing immunity to HIV through APOBEC","volume":"26","author":"Harris","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib37","doi-asserted-by":"crossref","first-page":"e1005958","DOI":"10.1371\/journal.ppat.1005958","article-title":"Evolutionary paradigms from ancient and ongoing conflicts between the lentiviral Vif protein and mammalian APOBEC3 enzymes","volume":"12","author":"Harris","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2017.10.007_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA determination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2017.10.007_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2015.03.012","article-title":"APOBECs and virus restriction","volume":"479-480","author":"Harris","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.chembiol.2017.10.007_bib40","doi-asserted-by":"crossref","first-page":"40875","DOI":"10.1074\/jbc.R112.416925","article-title":"The restriction factors of human immunodeficiency virus","volume":"287","author":"Harris","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib41","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/nar\/gkt246","article-title":"APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure","volume":"41","author":"Holtz","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2017.10.007_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11030-013-9424-3","article-title":"Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors","volume":"17","author":"Huang","year":"2013","journal-title":"Mol. Divers."},{"key":"10.1016\/j.chembiol.2017.10.007_bib43","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/cbdd.12119","article-title":"Indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors","volume":"81","author":"Huang","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.chembiol.2017.10.007_bib44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrclinonc.2016.165","article-title":"Genetics: APOBEC conundrum solved","volume":"13","author":"Hutchinson","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12185-015-1762-8","article-title":"The RUNX1-PU.1 axis in the control of hematopoiesis","volume":"101","author":"Imperato","year":"2015","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib46","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0969-2126(03)00153-9","article-title":"The 1.14 A crystal structure of yeast cytosine deaminase: evolution of nucleotide salvage enzymes and implications for genetic chemotherapy","volume":"11","author":"Ireton","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.chembiol.2017.10.007_bib47","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1093\/nar\/gkm750","article-title":"Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G","volume":"35","author":"Iwatani","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2017.10.007_bib48","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1128\/JVI.02680-05","article-title":"Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect","volume":"80","author":"Iwatani","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature10693","article-title":"Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection","volume":"481","author":"Jager","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2017.10.007_bib50","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1128\/JVI.75.17.7973-7986.2001","article-title":"Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T\u00a0cells","volume":"75","author":"Janini","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/geno.2002.6718","article-title":"An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22","volume":"79","author":"Jarmuz","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.chembiol.2017.10.007_bib52","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1021\/bi011849a","article-title":"Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 \u00c5 resolution","volume":"41","author":"Johansson","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2017.10.007_bib53","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1126\/science.3006245","article-title":"Identification of HTLV-III\/LAV sor gene product and detection of antibodies in human sera","volume":"231","author":"Kan","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2017.10.007_bib54","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1128\/JVI.79.9.5870-5874.2005","article-title":"Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes","volume":"79","author":"Khan","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib55","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1371\/journal.pgen.0030063","article-title":"Population stratification of a common APOBEC gene deletion polymorphism","volume":"3","author":"Kidd","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.chembiol.2017.10.007_bib56","doi-asserted-by":"crossref","first-page":"e1004281","DOI":"10.1371\/journal.ppat.1004281","article-title":"Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection","volume":"10","author":"Kim","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2017.10.007_bib57","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.1128\/JVI.01223-10","article-title":"Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure","volume":"84","author":"Kim","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib58","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nsmb.2378","article-title":"The APOBEC3C crystal structure and the interface for HIV-1 Vif binding","volume":"19","author":"Kitamura","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tig.2015.10.005","article-title":"DNA editing by APOBECs: a genomic preserver and transformer","volume":"32","author":"Knisbacher","year":"2016","journal-title":"Trends Genet."},{"key":"10.1016\/j.chembiol.2017.10.007_bib60","doi-asserted-by":"crossref","first-page":"19111","DOI":"10.1074\/jbc.M300874200","article-title":"Crystal structure of yeast cytosine deaminase. Insights into enzyme mechanism and evolution","volume":"278","author":"Ko","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib61","doi-asserted-by":"crossref","first-page":"40956","DOI":"10.1074\/jbc.M110.177402","article-title":"Local sequence targeting in the AID\/APOBEC family differentially impacts retroviral restriction and antibody diversification","volume":"285","author":"Kohli","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib62","doi-asserted-by":"crossref","first-page":"15024","DOI":"10.1038\/ncomms15024","article-title":"Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity","volume":"8","author":"Kouno","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2017.10.007_bib63","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/JVI.01976-08","article-title":"Guidelines for naming nonprimate APOBEC3 genes and proteins","volume":"83","author":"LaRue","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib64","doi-asserted-by":"crossref","first-page":"e1601737","DOI":"10.1126\/sciadv.1601737","article-title":"The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer","volume":"2","author":"Law","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.chembiol.2017.10.007_bib65","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.1083338","article-title":"Hypermutation of HIV-1 DNA in the absence of the Vif protein","volume":"300","author":"Lecossier","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2017.10.007_bib66","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.3006243","article-title":"A new HTLV-III\/LAV protein encoded by a gene found in cytopathic retroviruses","volume":"231","author":"Lee","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2017.10.007_bib67","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.celrep.2015.10.068","article-title":"Identification of the HIV-1 Vif and human APOBEC3G protein interface","volume":"13","author":"Letko","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.chembiol.2017.10.007_bib68","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/cb200440y","article-title":"First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G","volume":"7","author":"Li","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib69","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1002\/jcb.23287","article-title":"Integration of BMP, Wnt, and Notch signaling pathways in osteoblast differentiation","volume":"112","author":"Lin","year":"2011","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib70","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.1128\/JVI.78.21.11841-11852.2004","article-title":"Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging","volume":"78","author":"Luo","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib71","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1039\/b612050d","article-title":"Three-dimensional structure of HIV-1 VIF constructed by comparative modeling and the function characterization analyzed by molecular dynamics simulation","volume":"5","author":"Lv","year":"2007","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib72","doi-asserted-by":"crossref","first-page":"a006940","DOI":"10.1101\/cshperspect.a006940","article-title":"HIV restriction factors and mechanisms of evasion","volume":"2","author":"Malim","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.chembiol.2017.10.007_bib73","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.chom.2008.04.008","article-title":"HIV-1 accessory proteins\u2014ensuring viral survival in a hostile environment","volume":"3","author":"Malim","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chembiol.2017.10.007_bib74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2017.10.007_bib75","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation","volume":"9","author":"Marin","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2017.10.007_bib76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1081\/NCN-200059765","article-title":"Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology","volume":"24","author":"Marquez","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.chembiol.2017.10.007_bib77","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1743-422X-11-122","article-title":"Small molecules that inhibit Vif-induced degradation of APOBEC3G","volume":"11","author":"Matsui","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.chembiol.2017.10.007_bib78","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1128\/JVI.00272-07","article-title":"Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration","volume":"81","author":"Mbisa","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib79","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1074\/jbc.M313093200","article-title":"Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway","volume":"279","author":"Mehle","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib80","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/genes8010046","article-title":"Risks at the DNA replication fork: effects upon carcinogenesis and tumor heterogeneity","volume":"8","author":"Mertz","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.chembiol.2017.10.007_bib81","doi-asserted-by":"crossref","first-page":"13346","DOI":"10.1128\/JVI.01361-07","article-title":"Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1","volume":"81","author":"Miyagi","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib82","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1021\/ml300037k","article-title":"SAR and lead optimization of an HIV-1 Vif-APOBEC3G axis inhibitor","volume":"3","author":"Mohammed","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2017.10.007_bib83","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1073\/pnas.0710190105","article-title":"Cytidine deamination induced HIV-1 drug resistance","volume":"105","author":"Mulder","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2017.10.007_bib84","doi-asserted-by":"crossref","first-page":"14225","DOI":"10.1073\/pnas.1306345110","article-title":"Nucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminase","volume":"110","author":"Nabel","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2017.10.007_bib85","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/JVI.02369-15","article-title":"Structural insights into HIV-1 Vif-APOBEC3F interaction","volume":"90","author":"Nakashima","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib86","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.1128\/JVI.00973-16","article-title":"In\u00a0vivo examination of mouse APOBEC3- and human APOBEC3A- and APOBEC3G-mediated restriction of parvovirus and herpesvirus infection in mouse models","volume":"90","author":"Nakaya","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib87","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nbt.1496","article-title":"Small-molecule inhibition of HIV-1 Vif","volume":"26","author":"Nathans","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cub.2004.12.068","article-title":"Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity","volume":"15","author":"Newman","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib89","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","article-title":"Mutational processes molding the genomes of 21 breast cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2017.10.007_bib90","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1021\/acs.jmedchem.5b00930","article-title":"Oxidative reactivities of 2-furylquinolines: ubiquitous scaffolds in common high-throughput screening libraries","volume":"58","author":"Olson","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib91","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cmdc.201200411","article-title":"Small-molecule APOBEC3G DNA cytosine deaminase inhibitors based on a 4-amino-1,2,4-triazole-3-thiol scaffold","volume":"8","author":"Olson","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.chembiol.2017.10.007_bib92","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2015.03.050","article-title":"Development of benzimidazole derivatives to inhibit HIV-1 replication through protecting APOBEC3G protein","volume":"95","author":"Pan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib93","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.virol.2015.06.014","article-title":"Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1","volume":"484","author":"Pery","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.chembiol.2017.10.007_bib94","doi-asserted-by":"crossref","first-page":"10504","DOI":"10.1074\/jbc.M114.626903","article-title":"Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein","volume":"290","author":"Pery","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib95","doi-asserted-by":"crossref","first-page":"19583","DOI":"10.1074\/jbc.C300114200","article-title":"In\u00a0vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1)","volume":"278","author":"Petersen-Mahrt","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib96","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.jmb.2013.07.040","article-title":"The local dinucleotide preference of APOBEC3G can be altered from 5\u2032-CC to 5\u2032-TC by a single amino acid substitution","volume":"425","author":"Rathore","year":"2013","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib97","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1074\/jbc.M807258200","article-title":"Dissecting APOBEC3G substrate specificity by nucleoside analog interference","volume":"284","author":"Rausch","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib98","first-page":"1","article-title":"The APOBEC3 family of retroelement restriction factors","volume":"371","author":"Refsland","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib99","doi-asserted-by":"crossref","first-page":"e1004761","DOI":"10.1371\/journal.pgen.1004761","article-title":"Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-a mutation levels and infectivity","volume":"10","author":"Refsland","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.chembiol.2017.10.007_bib100","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.celrep.2015.10.067","article-title":"The binding interface between human APOBEC3F and HIV-1 Vif elucidated by genetic and computational approaches","volume":"13","author":"Richards","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.chembiol.2017.10.007_bib101","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jmb.2016.11.012","article-title":"Reassessing APOBEC3G inhibition by HIV-1 Vif-derived peptides","volume":"429","author":"Richards","year":"2017","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-pathol-020712-164004","article-title":"Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase","volume":"8","author":"Robbiani","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib103","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2017.10.007_bib104","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tibs.2016.05.001","article-title":"The APOBEC protein family:\u00a0united by structure, divergent in function","volume":"41","author":"Salter","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.chembiol.2017.10.007_bib105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2004.08.006","article-title":"Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor","volume":"328","author":"Schafer","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.chembiol.2017.10.007_bib106","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1128\/JVI.02391-07","article-title":"The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction","volume":"82","author":"Schumacher","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib132","doi-asserted-by":"crossref","unstructured":"Shaban, N.M., Shi, K., Lauer, K.V., Carpenter, M.A., Richards, C.M., Lopresti, M.W., Salamango, D., Wang, J., Banerjee, S., Brown, W.L., et al. (2017). bioRxiv 203000; https:\/\/doi.org\/10.1101\/203000.","DOI":"10.1101\/203000"},{"key":"10.1016\/j.chembiol.2017.10.007_bib107","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.jmb.2016.04.026","article-title":"1.92 angstrom zinc-free APOBEC3F catalytic domain crystal structure","volume":"428","author":"Shaban","year":"2016","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib108","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif","volume":"9","author":"Sheehy","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2017.10.007_bib109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nsmb.3344","article-title":"Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B","volume":"24","author":"Shi","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib110","doi-asserted-by":"crossref","first-page":"28120","DOI":"10.1074\/jbc.M115.679951","article-title":"Crystal structure of the DNA deaminase APOBEC3B catalytic domain","volume":"290","author":"Shi","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib111","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12672-014-0196-8","article-title":"Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers","volume":"5","author":"Sieuwerts","year":"2014","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.chembiol.2017.10.007_bib112","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1568026615666150112114337","article-title":"An in\u00a0silico approach for identification of novel inhibitors as a potential therapeutics targeting HIV-1 viral infectivity factor","volume":"15","author":"Sinha","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib113","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.tips.2009.09.006","article-title":"Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development","volume":"30","author":"Smith","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.chembiol.2017.10.007_bib114","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.3006244","article-title":"Replicative and cytopathic potential of HTLV-III\/LAV with sor gene deletions","volume":"231","author":"Sodroski","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2017.10.007_bib115","first-page":"24","article-title":"Development of lentiviral vectors simultaneously expressing multiple siRNAs against CCR5, Vif and tat\/rev genes for an HIV-1 gene therapy approach","volume":"19","author":"Spanevello","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.chembiol.2017.10.007_bib116","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/328728a0","article-title":"The HIV 'A' (sor) gene product is essential for virus infectivity","volume":"328","author":"Strebel","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2017.10.007_bib117","doi-asserted-by":"crossref","first-page":"35822","DOI":"10.1074\/jbc.M405761200","article-title":"Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs","volume":"279","author":"Svarovskaia","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib118","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1128\/JVI.67.8.4945-4955.1993","article-title":"Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells","volume":"67","author":"von Schwedler","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib119","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.20092238","article-title":"Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID","volume":"207","author":"Wang","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chembiol.2017.10.007_bib120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0168-9525(03)00054-4","article-title":"Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business","volume":"19","author":"Wedekind","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.chembiol.2017.10.007_bib121","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1073\/pnas.1219702110","article-title":"Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration","volume":"110","author":"Weil","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2017.10.007_bib122","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/ar00007a004","article-title":"Testing the limits of protein-ligand binding discrimination with transition-state analogue inhibitors","volume":"24","author":"Wolfenden","year":"1991","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.chembiol.2017.10.007_bib123","doi-asserted-by":"crossref","first-page":"8114","DOI":"10.1073\/pnas.0400493101","article-title":"The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1","volume":"101","author":"Xie","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2017.10.007_bib124","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1074\/jbc.M606864200","article-title":"Virion-associated uracil DNA glycosylase-2 and apurinic\/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA","volume":"282","author":"Yang","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nsmb758","article-title":"Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome","volume":"11","author":"Yu","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chembiol.2017.10.007_bib126","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2017.10.007_bib127","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2017.10.007_bib128","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature10718","article-title":"T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction","volume":"481","author":"Zhang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2017.10.007_bib129","doi-asserted-by":"crossref","first-page":"22532","DOI":"10.1039\/c3ra42291g","article-title":"Exploring the binding mode of HIV-1 Vif inhibitors by blind docking, molecular dynamics and MM\/GBSA","volume":"3","author":"Zhou","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.chembiol.2017.10.007_bib130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejmech.2017.01.010","article-title":"Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists","volume":"129","author":"Zhou","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.chembiol.2017.10.007_bib131","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1128\/JVI.06957-11","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC","volume":"86","author":"Zuo","year":"2012","journal-title":"J.\u00a0Virol."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945617303884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945617303884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T02:50:22Z","timestamp":1750992622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945617303884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2451945617303884"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2017.10.007","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOBEC Enzymes as Targets for Virus and Cancer Therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}